These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33120049)

  • 1. Trimethylamine N-Oxide increases soluble fms-like tyrosine Kinase-1 in human placenta via NADPH oxidase dependent ROS accumulation.
    Chang QX; Chen X; Ming-Xin Yang ; Zang NL; Li LQ; Zhong N; Xia LX; Huang QT; Zhong M
    Placenta; 2021 Jan; 103():134-140. PubMed ID: 33120049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of PAR-1/NADPH oxidase/ROS signaling pathways is crucial for the thrombin-induced sFlt-1 production in extravillous trophoblasts: possible involvement in the pathogenesis of preeclampsia.
    Huang QT; Chen JH; Hang LL; Liu SS; Zhong M
    Cell Physiol Biochem; 2015; 35(4):1654-62. PubMed ID: 25824463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
    Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
    Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia.
    Huang QT; Wang SS; Zhang M; Huang LP; Tian JW; Yu YH; Wang ZJ; Zhong M
    Placenta; 2013 Oct; 34(10):949-52. PubMed ID: 23899470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
    Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
    Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; possible involvement in the pathogenesis of preeclampsia.
    Zhao Y; Koga K; Osuga Y; Nagai M; Izumi G; Takamura M; Harada M; Hirota Y; Yoshino O; Taketani Y
    Fertil Steril; 2012 Oct; 98(4):917-21. PubMed ID: 22819145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
    Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S
    PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sirtuin 1 deficiency on trophoblasts and its implications in the pathogenesis of pre-eclampsia.
    Yu H; Chen L; Du P; Liu X; Xia Y
    J Obstet Gynaecol; 2023 Dec; 43(2):2282103. PubMed ID: 37966393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
    Gu Y; Lewis DF; Wang Y
    J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioflavonoid luteolin prevents sFlt-1 release via HIF-1α inhibition in cultured human placenta.
    Eddy AC; Chiang CY; Rajakumar A; Spradley FT; Dauer P; Granger JP; Rana S
    FASEB J; 2023 Aug; 37(8):e23078. PubMed ID: 37405762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
    Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Tuohey L; Parry LJ; Senadheera S; Illanes SE; Kaitu'u-Lino TJ; Tong S
    Am J Obstet Gynecol; 2016 Mar; 214(3):356.e1-356.e15. PubMed ID: 26721779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.